Situation:
Start up biotech with novel oncology pipeline, built on proprietary animal models thought to be predictive of certain cancers, were in need of rapid completion of a Phase 1 study to secure additional venture funding.
Solutions:
- Halloran established a working relationship on behalf of the company with the Phase 1 unit.
- Negotiated a contract that minimized up-front cash and placed strong incentives on the CRO to complete the study and deliver data at agreed time points.
- Halloran maintained daily communication links with the unit and worked with the client to ensure ongoing and consistent flow of progress reports and data.
Value:
The client received data as scheduled and was able to secure funding. The client subsequently asked Halloran to assist in building an entire clinical group with associated quality management of all clinical vendors.